Neuronal Interfaces in Bioelectronic Medicines for Unlocking Therapeutic Potential for ANS Issues

Curr Drug Res Rev. 2026 Jul 2. doi: 10.2174/0125899775400493260619135138. Online ahead of print.ABSTRACTINTRODUCTION: Bioelectronic devices that alter autonomic nervous system (ANS) activity to treat a variety of disorders have been made possible by developments in neurotechnology, micro/nano-engine

N None Gunjan

Electroconvulsive Therapy as a Trigger for Takotsubo Cardiomyopathy

J Brown Hosp Med. 2026 Jul 1;5(3):162048. doi: 10.56305/001c.162048. eCollection 2026.ABSTRACTTakotsubo cardiomyopathy (TCM) is a transient stress-induced cardiomyopathy characterized by acute left ventricular systolic dysfunction in the absence of obstructive coronary artery disease. Electroconvuls

M My Anh Nguyen

Comprehensive Framework of Heart Failure with Preserved Ejection Fraction Management for Hospitalists: A Scoping Review

J Brown Hosp Med. 2026 Jul 1;5(3):163599. doi: 10.56305/001c.163599. eCollection 2026.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases and remains a major source of morbidity and hospitalization, particularly among older adults with m

J Jeffery Northway

Association between clinical features of isolated coronary artery ectasia and circulating levels of inflammatory markers

SAGE Open Med. 2026 Jul 1;14:20503121261463207. doi: 10.1177/20503121261463207. eCollection 2026.ABSTRACTBACKGROUND AND AIMS: Coronary artery ectasia (CAE) can lead to adverse clinical outcomes, including coronary spasm, thrombosis, dissection and myocardial ischaemia. In patients with isolated CAE-

J Junping Ou

Prospective feasibility study of a telehealth platform for community-based NCD risk assessment by community health leaders in rural northern Thailand

SAGE Open Med. 2026 Jul 4;14:20503121261465826. doi: 10.1177/20503121261465826. eCollection 2026.ABSTRACTINTRODUCTION: Limited access to preventive healthcare in rural and remote areas poses a persistent challenge for early identification of non-communicable disease (NCD) risk. We evaluated the feas

S Sujittra Kaewkart

CD109 exhibits a dynamic expression pattern in coronary endothelium and endocardial-derived valve mesenchyme during heart development with preserved morphogenesis following endothelial-specific deletion

Front Cell Dev Biol. 2026 Jun 19;14:1867997. doi: 10.3389/fcell.2026.1867997. eCollection 2026.ABSTRACTBACKGROUND: CD109 encodes a GPI-linked glycoprotein that acts as a signaling modulator in the TGF-β pathway. CD109 has emerged in several genome-wide association studies as linked to coronary arter

A Andrew B Harvey

Reduced regadenoson dose using heart rate-targeted titration in paediatric stress perfusion CMR

Eur Heart J Imaging Methods Pract. 2026 Jun 15;4(3):qyag108. doi: 10.1093/ehjimp/qyag108. eCollection 2026 Aug.ABSTRACTAIMS: Weight-based regadenoson dosing for paediatric stress perfusion cardiac magnetic resonance (CMR) achieves coronary vasodilation but may result in excessive drug exposure in so

M Michael A Quail

Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease: A Narrative Review

Gastro Hep Adv. 2026 May 28;5(9):101023. doi: 10.1016/j.gastha.2026.101023. eCollection 2026.ABSTRACTGlucagon-like peptide-1 receptor agonists (GLP-1RAs) have progressed from the initial discovery of endogenous GLP-1 biology in 1986 to widely used therapies for type 2 diabetes and obesity, with expa

A Aakash Desai

Adherence to Antihypertensive Medication and Its Associated Factors Among Patients with Hypertension Attending a Tertiary Hospital in Mogadishu, Somalia: A Cross-Sectional Study

Patient Prefer Adherence. 2026 Jun 29;20:607701. doi: 10.2147/PPA.S607701. eCollection 2026.ABSTRACTBACKGROUND: Hypertension is the leading modifiable risk factor for cardiovascular disease and premature mortality worldwide. In Somalia, the national hypertension control rate is estimated at only 10%

O Omar Mohamed Shukri

Population attributable fraction of cardiovascular disease, coronary heart disease, and stroke associated with insufficient non-occupational physical activity in Iranian adults: findings from the STEPS 2021 survey

J Diabetes Metab Disord. 2026 Jul 2;25(2):182. doi: 10.1007/s40200-026-01992-7. eCollection 2026 Dec.ABSTRACTBACKGROUND: Insufficient physical activity (IPA) is a well-established cardiovascular risk factor. Iran has one of the highest cardiovascular disease (CVD) burdens in the Middle East and Nort

M Mohammadamin Sabbagh Alvani

Mobile caseous mitral annular calcification as a cause of recurrent cardioembolic stroke: a case report

Eur Heart J Case Rep. 2026 Jun 25;10(7):ytag471. doi: 10.1093/ehjcr/ytag471. eCollection 2026 Jul.ABSTRACTBACKGROUND: Caseous mitral annular calcification (CMAC) is a rare variant of mitral annular calcification that may occasionally lead to systemic embolization.CASE SUMMARY: We report the case of

E Elsa Hoti

Genomic structural equation modeling elucidates the genetic mechanisms underlying allostatic load

Compr Psychoneuroendocrinol. 2026 Jun 25;27:100357. doi: 10.1016/j.cpnec.2026.100357. eCollection 2026 Aug.ABSTRACTBACKGROUND: Allostatic load (AL) represents the cumulative physiological burden arising from chronic stress across neuroendocrine, immune, metabolic, and cardiovascular systems. Althoug

S Songhao Chai

Right Ventricular Implantation of an Aveir™ AR Device for Bradycardia in a 90-Year-Old Woman with Atrial Fibrillation and Small Right Ventricular Dimensions

J Innov Card Rhythm Manag. 2026 Jun 15;17(6):6754-6757. doi: 10.19102/icrm.2026.17061. eCollection 2026 Jun.ABSTRACTWe report a case of implanting an Aveir™ AR (atrial) leadless pacemaker (Abbott, Chicago, IL, USA) in the right ventricle (RV) of a 90-year-old woman with permanent atrial fibrillation

A Ali Sovari

Cholesterol in amyotrophic lateral sclerosis: a bystander, a biomarker, or a target?

Atheroscler Plus. 2026 Jun 24;65:100576. doi: 10.1016/j.athplu.2026.100576. eCollection 2026 Sep.ABSTRACTAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron loss. In addition to the different pathogenic mechanisms, in recent years, incr

M Matteo Farè

Clinical Disease Burden in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation in Japan: A Retrospective Database Analysis (EUROS Study)

Int J Chron Obstruct Pulmon Dis. 2026 Jun 30;21:586341. doi: 10.2147/COPD.S586341. eCollection 2026.ABSTRACTPURPOSE: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Preventing COPD exacerbations is a primary goal in disease management. A subset of

S Shigeo Muro

Quality and reliability of cardiac rehabilitation-related short Chinese videos on Douyin and Bilibili: a cross-sectional content analysis

Front Public Health. 2026 Jun 19;14:1797405. doi: 10.3389/fpubh.2026.1797405. eCollection 2026.ABSTRACTBACKGROUND: Social media platforms have emerged as prominent channels for disseminating cardiovascular health information. However, the accuracy, completeness, and clinical reliability of cardiac r

J Jie Yuan

Circadian control of immune homeostasis in cardiovascular health and disease

Front Immunol. 2026 Jun 19;17:1867223. doi: 10.3389/fimmu.2026.1867223. eCollection 2026.ABSTRACTThe circadian system is an important regulator of cardiovascular immune homeostasis. Emerging evidence suggests that daily timing of immune responses may influence cardiovascular disease progression by c

Z Zhaoshan Zhang

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry

Front Immunol. 2026 Jun 19;17:1709085. doi: 10.3389/fimmu.2026.1709085. eCollection 2026.ABSTRACTOrbital inflammation is the most common presentation of VEXAS, with any orbital structure potentially affected. Non-sight-threatening and uncomplicated anterior non-granulomatous uveitis and anterior dif

J Jurgen Sota

Cardiovascular event rate modifies response to pharmacologic LDL-C lowering in primary prevention: implications of a systematic review and meta-analysis for clinical practice

Am J Prev Cardiol. 2026 May 25;28:101655. doi: 10.1016/j.ajpc.2026.101655. eCollection 2026 Aug.ABSTRACTBACKGROUND: LDL-C lowering is often delayed in lower-risk primary-prevention settings as absolute benefits appear modest. Trial evidence for greater relative benefits from pharmacologic LDL-C lowe

I Irene Karungi

The impact of bempedoic acid on cardiovascular events across the spectrum of kidney function, a CLEAR Outcomes trial secondary analysis

No abstractAm J Prev Cardiol. 2026 Apr 18;28:101645. doi: 10.1016/j.ajpc.2026.101645. eCollection 2026 Aug.NO ABSTRACTPMID:42404862 | PMC:PMC13331964 | DOI:10.1016/j.ajpc.2026.101645

C Carolina P Zingano

Preconception cardiometabolic health and adverse pregnancy outcomes in hispanic and latina women: Expanding the prevention window

No abstractAm J Prev Cardiol. 2026 Mar 20;28:101571. doi: 10.1016/j.ajpc.2026.101571. eCollection 2026 Aug.NO ABSTRACTPMID:42404861 | PMC:PMC13330654 | DOI:10.1016/j.ajpc.2026.101571

P Priyanka Satish

Resistance training in older adults: are the gains worth the strain?

No abstractAm J Prev Cardiol. 2026 Mar 19;28:101569. doi: 10.1016/j.ajpc.2026.101569. eCollection 2026 Aug.NO ABSTRACTPMID:42404860 | PMC:PMC13330651 | DOI:10.1016/j.ajpc.2026.101569

B Bradley J Petek

Synergistic modulation of the gut microbiome-liver-host metabolome axis associates with the therapeutic efficacy of Danlou tablet against metabolic syndrome

Front Microbiol. 2026 Jun 19;17:1808318. doi: 10.3389/fmicb.2026.1808318. eCollection 2026.ABSTRACTBACKGROUND: Obesity drives chronic diseases such as cardiovascular disease and diabetes. Danlou tablet (DLT), a traditional Chinese medicine formula, is used to treat coronary heart disease by regulati

M Minghe Yao

Gut microbiota-mediated cardiovascular effects of Gastrodia elata polysaccharides: resolving the bioavailability-efficacy paradox

Front Microbiol. 2026 Jun 10;17:1868003. doi: 10.3389/fmicb.2026.1868003. eCollection 2026.ABSTRACTBACKGROUND: Growing evidence suggests that many plant-derived polysaccharides exert systemic effects through gut microbiota-mediated mechanisms rather than direct absorption. Gastrodia elata polysaccha

Z Ziyi Luo